Salesforce director Craig Conway sells $1.17m in stock

CRM is still trading like a long-duration asset, so the bigger driver near term is rates rather than the insider sale itself. If the market keeps repricing the Fed path upward, the most immediate loser is high-multiple software with long-dated AI monetization narratives; BAC benefits mechanically from a higher-rate backdrop, but the cleaner expression is a rotation out of software beta into financials and cash-flow compounders over the next 1-4 weeks.

For CRM, the second-order issue is that the stock has already moved ahead of proof. Consensus appears to be extrapolating AI-driven pricing power into the outer years, but the first place that thesis can break is not headline demand — it is slower conversion of pipeline into billings, weaker renewal economics, or margin giveback from AI infrastructure/partner costs over the next 1-3 quarters. A further rise in 10Y yields would pressure the multiple even if fundamentals stay intact; conversely, a stable yield backdrop and another guide-up would likely reinforce the bull case into the next earnings cycle.

The contrarian view is that the insider sale is probably just liquidity, while the market is underestimating how much of the upside is already embedded in target raises. The stock can still work over 6-18 months if AI pricing becomes real revenue, but the risk/reward is less attractive after a 29% run unless management proves acceleration faster than the current guidance path. Watch for a post-earnings reset or a yield-driven pullback as the better entry; absent that, chasing here looks asymmetric only if rates roll over.